chr8-89953369-A-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_002485.5(NBN):c.1720T>A(p.Leu574Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00087 in 1,613,254 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002485.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NBN | NM_002485.5 | c.1720T>A | p.Leu574Ile | missense_variant | 11/16 | ENST00000265433.8 | NP_002476.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NBN | ENST00000265433.8 | c.1720T>A | p.Leu574Ile | missense_variant | 11/16 | 1 | NM_002485.5 | ENSP00000265433.4 |
Frequencies
GnomAD3 genomes AF: 0.000474 AC: 72AN: 151762Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000721 AC: 181AN: 251186Hom.: 2 AF XY: 0.000655 AC XY: 89AN XY: 135786
GnomAD4 exome AF: 0.000911 AC: 1332AN: 1461374Hom.: 3 Cov.: 32 AF XY: 0.000882 AC XY: 641AN XY: 727014
GnomAD4 genome AF: 0.000474 AC: 72AN: 151880Hom.: 0 Cov.: 32 AF XY: 0.000364 AC XY: 27AN XY: 74234
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:7
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 21, 2021 | This variant is associated with the following publications: (PMID: 15855896, 23555315, 28135145, 27621404, 29458332, 26928227, 14684699, 27978560, 24728327, 26787654, 26315354, 26976419) - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 18, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jul 31, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 11, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 09, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden | Nov 03, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2020 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Microcephaly, normal intelligence and immunodeficiency Benign:4
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | May 18, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Aug 14, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Likely benign, criteria provided, single submitter | clinical testing | Counsyl | Apr 16, 2018 | - - |
Hereditary cancer-predisposing syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Likely benign, criteria provided, single submitter | curation | Sema4, Sema4 | Dec 08, 2020 | - - |
not specified Benign:1Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 17, 2018 | - - |
Malignant tumor of breast Benign:1
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | NBN, EXON11, c.1720T>A, p.Leu574Ile, Heterozygous, Likely Benign The NBN p.Leu574Ile variant was identified in 7 of 8650 proband chromosomes (frequency 0.0008) from individuals or families with breast and/or ovarian cancer or colorectal cancer and was present in 9 of 8838 (frequency 0.001) control chromosomes from healthy individuals (Heikkinen_2003_14684699, Tung_2016_26976419, Pearlman_2016_27978560, Ramus_2015_26315354, Bodian_2014_24728327). The variant was also identified in the following databases: dbSNP (ID: rs142334798) as “With Uncertain significance, other allele”, ClinVar and Clinvitae databases (4x classified as uncertain significance by Invitae, University of Chicago, Quest Diagnostics, ARUP; 2x classified as likely benign by Ambry Genetics and GeneDx; 1x no classification by ITMI), and the Zhejiang Colon Cancer Database (1x classified as probably pathogenic; 1x classified as pathogenicity unknown). The variant was not identified in the COSMIC or LOVD 3.0 databases. The variant was identified in control databases in 192 of 276828 chromosomes (2 homozygous) at a frequency of 0.0007 increasing the likelihood this could be a low frequency variant (Genome Aggregation Database Feb 27, 2017). Observations by population included African in 1 of 24004 chromosomes (freq: 0.000042), “Other” in 3 of 6456 chromosomes (freq: 0.000465), Latino in 3 of 34414 chromosomes (freq: 0.000087), European Non-Finnish in 130 of 126478 chromosomes (freq: 0.001028), European Finnish in 37 of 25688 chromosomes (freq: 0.00144), and South Asian in 18 of 30778 chromosomes (freq: 0.000585); the variant was not observed in the Ashkenazi Jewish, or East Asian populations. The p.Leu574Ile residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 1 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at